Reinhard Marks

Peripheral deletion of antigen-reactive T cells in oral tolerance

Youhai Chen, Jun-ichi Inobe, Reinhard Marks et al. · Nature · 1995 · 785 citations

Life Sciences, Immunology, Oral Biology +16

Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia

Max S. Topp, Nicola Gökbuget, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2014 · 659 citations

Medicine, Hematology, Oncology +15

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke et al. · Leukemia · 2015 · 540 citations · Full text

Medicine, Clinical Sciences, Immunology +16

High-Dose Chemotherapy With Autologous Stem-Cell Transplantation and Hyperfractionated Radiotherapy As First-Line Treatment of Primary CNS Lymphoma

Gerald Illerhaus, Reinhard Marks, Gabriele Ihorst et al. · Journal of Clinical Oncology · 2006 · 296 citations

Medicine, Oncology, Radiation Oncology +13

T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-α

Yuanyuan Zha, Reinhard Marks, Allen W. Ho et al. · Nature Immunology · 2006 · 266 citations

Life Sciences, Cell Biology, Immunology +16